MwanzoDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
$ 7.84
Baada ya Saa za Kazi:(1.15%)+0.090
$ 7.93
Imefungwa: 25 Apr, 18:37:44 GMT -4 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 7.87
Bei za siku
$ 7.61 - $ 7.95
Bei za mwaka
$ 5.00 - $ 45.20
Thamani ya kampuni katika soko
431.46M USD
Wastani wa hisa zilizouzwa
1.42M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 43.85M | 26.16% |
Matumizi ya uendeshaji wa biashara | 128.36M | -29.52% |
Mapato halisi | -107.53M | 49.20% |
Kiwango cha faida halisi | -245.25 | 59.74% |
Mapato kwa kila hisa | -1.21 | 58.78% |
EBITDA | -78.48M | 44.39% |
Asilimia ya kodi ya mapato | 0.30% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 561.57M | -40.52% |
Jumla ya mali | 1.38B | -17.29% |
Jumla ya dhima | 661.39M | 16.40% |
Jumla ya hisa | 716.06M | — |
hisa zilizosalia | 54.37M | — |
Uwiano wa bei na thamani | 0.60 | — |
Faida inayotokana na mali | -16.47% | — |
Faida inayotokana mtaji | -19.39% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -107.53M | 49.20% |
Pesa kutokana na shughuli | -42.44M | 26.62% |
Pesa kutokana na uwekezaji | -13.08M | 71.97% |
Pesa kutokana na ufadhili | elfu -203.00 | 67.88% |
Mabadiliko halisi ya pesa taslimu | -55.80M | 46.88% |
Mtiririko huru wa pesa | -64.47M | -146.17% |
Kuhusu
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2008
Makao Makuu
Tovuti
Wafanyakazi
834
